ACN vs ATXS · P/E 24, rev $17.60B vs rev $706.0K
Accenture plc (ACN) versus Astria Therapeutics Inc (ATXS) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. ATXS currently screens at market cap $382.1M.
Not investment advice. Open the ACN and ATXS stock pages for the full models.
Not investment advice.